Features
Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border...
Major new regulation is on its way for medicinal packaging in the fight against illicit medicines, but these big plans are not without a few...
Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen's EMEA operations to discuss nearly three decades at the company,...
The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves assesses some of the major...
Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the company’s...
Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social media can prove invaluable for...
On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout from the...
There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues Tom Cowap of...
Merck KGaA's Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and German firms which bear the name...
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal products available to...
